Lomé, August 12, 2026 — The future of healthcare in West Africa hinges on a single decision: will the region continue importing most of its medicines, or will it build a robust local pharmaceutical industry? This critical crossroads was the focal point of a high-level regional medical and academic gathering held at the Agora Senghor in Lomé, where delegates laid the groundwork for a complete overhaul of West Africa’s health strategy.
The 21st edition of the Federation of West African Pharmacy Students (FESPAO) Scientific and Cultural Conference brought together the continent’s brightest medical minds—not just to discuss funding gaps, but to demand a fundamental shift in healthcare doctrine. The era of relying solely on imported pharmaceuticals is ending. Instead, delegates emphasized industrialization, genomic research, and the scientific validation of traditional knowledge as the pillars of a new health paradigm.
Local production: a national security imperative
The global pandemic and recent supply chain disruptions exposed a harsh truth: Africa’s reliance on foreign pharmaceutical imports is not merely an economic burden—it poses a severe national security risk. This was the rallying cry at the summit.
Professor Gado Tchangbédji, Togo’s Minister Delegate for Higher Education and Research, outlined the government’s strategic vision under President Faure Essozimna Gnassingbé. The goal? To position innovation and local pharmaceutical production as the continent’s first line of defense against future pandemics. To achieve this, the state is committing substantial resources to foster scientific cooperation and applied research.
Genomic epidemiology and indigenous knowledge: the path to true sovereignty
Local production alone won’t suffice if it merely replicates foreign patents. True pharmaceutical sovereignty requires tailoring treatments to Africa’s unique genetic and epidemiological landscape. The Lomé conference placed genomic epidemiology at the heart of discussions, highlighting an urgent need: developing therapies aligned with the genetic makeup of African populations, which have long been underrepresented in global clinical trials.
This forward-thinking approach is paired with a bold cultural reappraisal. Experts are advocating for the formal industrialization of traditional medicine. No longer should herbal remedies remain informal or unregulated. Instead, they must undergo rigorous clinical trials to identify and patent active compounds rooted in 100% African pharmacopeia.
Rethinking the pharmacist’s role in West Africa
Yet, this industrial and scientific ambition faces a critical bottleneck: human capital. As the sector evolves, so must academic training. Professor Tchin Darré, Togo’s Minister Delegate for Health and Dean of the Faculty of Health Sciences at the University of Lomé, pinpointed the heart of this transformation: curriculum reform.
The West African pharmacist of tomorrow cannot remain a simple dispenser of pre-packaged medicines from behind a counter. The profession must evolve into a multidisciplinary role—part cutting-edge researcher, part manufacturing specialist, and part authority on validating indigenous knowledge. The 21st edition of the FESPAO conference is not just about dialogue; it’s about drafting binding public policy proposals to ensure universal healthcare access in West Africa is no longer dependent on factories thousands of kilometers away.
The stakes could not be higher. Without a strong local pharmaceutical industry and research ecosystem rooted in African realities, West Africa will remain at the mercy of solutions designed elsewhere. Future pandemics could make this dependency a matter of life and death. True health sovereignty will be measured by the continent’s ability to turn these resolutions into tangible action—ensuring every patient in West Africa receives care designed, validated, and produced on African soil.
